trial · primary record
Valemetostat
Metastatic Castration-resistant Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2029-11-30 |
| Primary endpoint | Part 1: Number of participants with Dose-Limiting Toxicities (DLTs) |
| Registry ID | NCT07244341 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:54.459Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07244341
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.